Javier Fuller
Arthritis is a crippling disease that afflicts a number of people across the world. With it you can be down with unbearable pain and might even find it hard to perform even the simplest of tasks. In a way, it brings a phenomenal disability to you.
The general notion that it hits you only after a certain age is, by and large, wrong. It is not
something that waits till you cross sixty years of age. It emerges as a dreadful disease in elderly if not taken care of properly and early enough. The point that it cannot affect the younger generation is wholly false. It affects people in the bracket of 35 and 45 years of age. In fact, it can emerge in the form of juvenile arthritis as well. And as the name suggests, this type of arthritis affects people at a very young age. It definitely calls for immediate attention.
While curing arthritis, early diagnosis is very important. Earlier, the better! Therefore, as and when you notice the symptoms of arthritis, you should rush to a specialist in order get yourself cured of this painful malady.
As far as treatment is concerned, extensive medical research has ensured that there are many
treatments available. A research recently conducted with as many as 6000 patients across 11 European nations in around 4000 centers showed remarkable results.
The patients, during the study, were injected with Adalimumab (40 mg) once in every 2 weeks for 12 weeks. Quite amazingly, the pain in 77% of cases came down to 3% from 13%. In 70% cases the swelling dwindled down to 3% from 10%. And around 25% of the patients reported
disappearance of pain in just 12 weeks. The results, therefore, have been very encouraging.
The problem, however, is the affordability of the treatment. They are prohibitively expensive. Besides, the medication might also have some serious side effects and, thus, has to be prescribed by a seasoned medical practitioner.
Visit www.about-disability.com/disability-and-health/ to know about insurance plans for disabled and rights of disabled Health and Fitness Related Articles
No comments:
Post a Comment